Standard treatment of severe autoimmune disorders is usually symptomatic, and, therefore, has rather limited success.
Introduction in clinical practice of already existing scientific developments of pathogenetic treatment of these diseases is an acute task of modern medicine.
The essence of one of such developments consists of induction of the immune reactions directed against autoimmune Т lymphocytes, responsible for the development of disease.
The method of Т-cellular vaccination includes 2 stages.
1. Increase of autoimmune T-lymphocytes outside the body.
2. Immunization (vaccination) by the patient's autoimmune lymphocytes .
The regime of vaccination can be optimized depending on the individual peculiarities of the patient.
Elimination of autoimmune lymphocytes from the body leads to steady clinical effect.
The specified treatment has no contra-indications and serious side effects.
The method of Т-cellular vaccination is applied for the treatment of multiple sclerosis and autoimmune glomerulonephritis. It is planned to use this method by the treatment of other autoimmune diseases.
For further information concerning treatment of multiple sclerosis and autoimmune disorders You may consult the specialists of The Institute of Biological Medicine - see section contacts.
